We've already taken steps to accommodate for that. With the capacity at the Northern RNA facility in Calgary partnered with the capacity of the Emergent BioSolutions facility in Manitoba, we have the ability to produce over 120 million doses of vaccine.
On February 16th, 2021. See this statement in context.